{"entity":{"type":"insider","cik":"0001598762","url":"/insider/0001598762","json_url":"/insider/0001598762.json","name":"Pharmstandard International S.A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":14,"first":"2014-02-12","last":"2016-10-13","span_basis":"filed_date"},"name_variants":[{"name":"Pharmstandard International S.A.","source":"filing","n_filings":14,"first_seen":"2014-02-12","last_seen":"2016-10-13"}],"transactions":[{"id":2819042,"accession":"0000904454-16-001492","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000904454-16-001492","line_url":"/filing/0000904454-16-001492#line-4","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Pharmstandard International S.A.; Public Joint Stock Co Pharmstandard","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21000.0,"shares_display":"21,000","price_per_share":4.73,"price_display":"4.73","price_state":"stated","total_value":99330.0,"total_display":"99,330.00","shares_owned_after":13242279.0,"shares_owned_after_display":"13,242,279","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-07","filed_date":"2016-10-13","scope":"insider"},{"id":2819037,"accession":"0000904454-16-001492","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-16-001492","line_url":"/filing/0000904454-16-001492#line-3","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Pharmstandard International S.A.; Public Joint Stock Co Pharmstandard","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2640.0,"shares_display":"2,640","price_per_share":4.81,"price_display":"4.81","price_state":"stated","total_value":12698.4,"total_display":"12,698.40","shares_owned_after":13221279.0,"shares_owned_after_display":"13,221,279","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-06","filed_date":"2016-10-13","scope":"insider"},{"id":2819034,"accession":"0000904454-16-001492","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001492","line_url":"/filing/0000904454-16-001492#line-2","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Pharmstandard International S.A.; Public Joint Stock Co Pharmstandard","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":4.85,"price_display":"4.85","price_state":"stated","total_value":4365.0,"total_display":"4,365.00","shares_owned_after":13218639.0,"shares_owned_after_display":"13,218,639","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-05","filed_date":"2016-10-13","scope":"insider"},{"id":2819030,"accession":"0000904454-16-001492","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001492","line_url":"/filing/0000904454-16-001492#line-1","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Pharmstandard International S.A.; Public Joint Stock Co Pharmstandard","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7164.0,"shares_display":"7,164","price_per_share":4.69,"price_display":"4.69","price_state":"stated","total_value":33599.16,"total_display":"33,599.16","shares_owned_after":13217739.0,"shares_owned_after_display":"13,217,739","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-04","filed_date":"2016-10-13","scope":"insider"},{"id":3274760,"accession":"0000904454-16-001467","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001467","line_url":"/filing/0000904454-16-001467#line-2","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Public Joint Stock Co Pharmstandard; Pharmstandard International S.A.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11308.0,"shares_display":"11,308","price_per_share":4.7,"price_display":"4.70","price_state":"stated","total_value":53147.6,"total_display":"53,147.60","shares_owned_after":13210875.0,"shares_owned_after_display":"13,210,875","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-04","scope":"insider"},{"id":3274750,"accession":"0000904454-16-001467","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001467","line_url":"/filing/0000904454-16-001467#line-1","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Public Joint Stock Co Pharmstandard; Pharmstandard International S.A.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30232.0,"shares_display":"30,232","price_per_share":4.71,"price_display":"4.71","price_state":"stated","total_value":142392.72,"total_display":"142,392.72","shares_owned_after":13199567.0,"shares_owned_after_display":"13,199,567","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-30","filed_date":"2016-10-04","scope":"insider"},{"id":3312410,"accession":"0000904454-16-001459","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001459","line_url":"/filing/0000904454-16-001459#line-2","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Public Joint Stock Co Pharmstandard; Pharmstandard International S.A.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15100.0,"shares_display":"15,100","price_per_share":4.6,"price_display":"4.60","price_state":"stated","total_value":69460.0,"total_display":"69,460.00","shares_owned_after":13169335.0,"shares_owned_after_display":"13,169,335","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-29","filed_date":"2016-09-30","scope":"insider"},{"id":3312407,"accession":"0000904454-16-001459","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001459","line_url":"/filing/0000904454-16-001459#line-1","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Public Joint Stock Co Pharmstandard; Pharmstandard International S.A.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28518.0,"shares_display":"28,518","price_per_share":4.54,"price_display":"4.54","price_state":"stated","total_value":129471.72,"total_display":"129,471.72","shares_owned_after":13154235.0,"shares_owned_after_display":"13,154,235","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-28","filed_date":"2016-09-30","scope":"insider"},{"id":2056675,"accession":"0000904454-16-001451","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001451","line_url":"/filing/0000904454-16-001451#line-2","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Public Joint Stock Co Pharmstandard; Pharmstandard International S.A.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":41259.0,"shares_display":"41,259","price_per_share":4.77,"price_display":"4.77","price_state":"stated","total_value":196805.43,"total_display":"196,805.43","shares_owned_after":13125717.0,"shares_owned_after_display":"13,125,717","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-20","filed_date":"2016-09-21","scope":"insider"},{"id":2056650,"accession":"0000904454-16-001451","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001451","line_url":"/filing/0000904454-16-001451#line-1","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Public Joint Stock Co Pharmstandard; Pharmstandard International S.A.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5580.0,"shares_display":"5,580","price_per_share":4.76,"price_display":"4.76","price_state":"stated","total_value":26560.8,"total_display":"26,560.80","shares_owned_after":13084458.0,"shares_owned_after_display":"13,084,458","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-19","filed_date":"2016-09-21","scope":"insider"},{"id":2626965,"accession":"0000904454-16-001445","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001445","line_url":"/filing/0000904454-16-001445#line-2","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Pharmstandard International S.A.; Public Joint Stock Co Pharmstandard","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":36632.0,"shares_display":"36,632","price_per_share":4.78,"price_display":"4.78","price_state":"stated","total_value":175100.96,"total_display":"175,100.96","shares_owned_after":13078578.0,"shares_owned_after_display":"13,078,578","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-16","filed_date":"2016-09-20","scope":"insider"},{"id":2626959,"accession":"0000904454-16-001445","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001445","line_url":"/filing/0000904454-16-001445#line-1","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Pharmstandard International S.A.; Public Joint Stock Co Pharmstandard","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15880.0,"shares_display":"15,880","price_per_share":4.76,"price_display":"4.76","price_state":"stated","total_value":75588.8,"total_display":"75,588.80","shares_owned_after":13041946.0,"shares_owned_after_display":"13,041,946","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-15","filed_date":"2016-09-20","scope":"insider"},{"id":3312402,"accession":"0000904454-16-001433","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001433","line_url":"/filing/0000904454-16-001433#line-1","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Public Joint Stock Co Pharmstandard; Pharmstandard International S.A.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16977.0,"shares_display":"16,977","price_per_share":4.78,"price_display":"4.78","price_state":"stated","total_value":81150.06,"total_display":"81,150.06","shares_owned_after":13026066.0,"shares_owned_after_display":"13,026,066","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-01","filed_date":"2016-09-07","scope":"insider"},{"id":2646663,"accession":"0000904454-16-001386","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001386","line_url":"/filing/0000904454-16-001386#line-2","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Public Joint Stock Co Pharmstandard; Pharmstandard International S.A.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":57772.0,"shares_display":"57,772","price_per_share":4.55,"price_display":"4.55","price_state":"stated","total_value":262862.6,"total_display":"262,862.60","shares_owned_after":12953865.0,"shares_owned_after_display":"12,953,865","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-24","filed_date":"2016-08-25","scope":"insider"},{"id":2361956,"accession":"0000904454-16-001393","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001393","line_url":"/filing/0000904454-16-001393#line-1","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Public Joint Stock Co Pharmstandard; Pharmstandard International S.A.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55224.0,"shares_display":"55,224","price_per_share":4.57,"price_display":"4.57","price_state":"stated","total_value":252373.68,"total_display":"252,373.68","shares_owned_after":13009089.0,"shares_owned_after_display":"13,009,089","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-24","filed_date":"2016-08-29","scope":"insider"},{"id":2646659,"accession":"0000904454-16-001386","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001386","line_url":"/filing/0000904454-16-001386#line-1","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Public Joint Stock Co Pharmstandard; Pharmstandard International S.A.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9599.0,"shares_display":"9,599","price_per_share":4.36,"price_display":"4.36","price_state":"stated","total_value":41851.64,"total_display":"41,851.64","shares_owned_after":12896093.0,"shares_owned_after_display":"12,896,093","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-23","filed_date":"2016-08-25","scope":"insider"},{"id":2311103,"accession":"0000904454-16-001380","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001380","line_url":"/filing/0000904454-16-001380#line-2","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Pharmstandard International S.A.; Public Joint Stock Co Pharmstandard","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21950.0,"shares_display":"21,950","price_per_share":4.26,"price_display":"4.26","price_state":"stated","total_value":93507.0,"total_display":"93,507.00","shares_owned_after":12886494.0,"shares_owned_after_display":"12,886,494","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-22","filed_date":"2016-08-23","scope":"insider"},{"id":2311098,"accession":"0000904454-16-001380","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001380","line_url":"/filing/0000904454-16-001380#line-1","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Pharmstandard International S.A.; Public Joint Stock Co Pharmstandard","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":53524.0,"shares_display":"53,524","price_per_share":4.23,"price_display":"4.23","price_state":"stated","total_value":226406.52,"total_display":"226,406.52","shares_owned_after":12864544.0,"shares_owned_after_display":"12,864,544","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-19","filed_date":"2016-08-23","scope":"insider"},{"id":3028488,"accession":"0000899243-16-026291","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-026291","line_url":"/filing/0000899243-16-026291#line-1","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Public Joint Stock Co Pharmstandard; Pharmstandard International S.A.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2363636.0,"shares_display":"2,363,636","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":12811020.0,"shares_owned_after_display":"12,811,020","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-02","filed_date":"2016-08-04","scope":"insider"},{"id":2989149,"accession":"0000904454-16-001302","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001302","line_url":"/filing/0000904454-16-001302#line-1","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Public Joint Stock Co Pharmstandard; Pharmstandard International S.A.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2678301.0,"shares_display":"2,678,301","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":10447384.0,"shares_owned_after_display":"10,447,384","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-29","filed_date":"2016-07-01","scope":"insider"},{"id":3240973,"accession":"0000904454-16-001129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001129","line_url":"/filing/0000904454-16-001129#line-1","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Public Joint Stock Co Pharmstandard; Pharmstandard International S.A.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1785534.0,"shares_display":"1,785,534","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":7769083.0,"shares_owned_after_display":"7,769,083","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-03-14","filed_date":"2016-03-16","scope":"insider"},{"id":6332426,"accession":"0001104659-14-074940","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-14-074940","line_url":"/filing/0001104659-14-074940#line-2","is_derivative":false,"issuer_cik":"0001359931","issuer_name":"PROTEON THERAPEUTICS INC","issuer_ticker":"PRTO","issuer_name_source":null,"issuer_url":"/issuer/0001359931","owner_cik":null,"owner_name":"Public Joint Stock Co Pharmstandard; Pharmstandard International S.A.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600000.0,"shares_display":"600,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":6000000.0,"total_display":"6,000,000.00","shares_owned_after":600000.0,"shares_owned_after_display":"600,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-27","filed_date":"2014-10-29","scope":"insider"},{"id":6344893,"accession":"0001209191-14-009833","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-009833","line_url":"/filing/0001209191-14-009833#line-2","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":null,"owner_name":"Pharmstandard International S.A.; Public Joint Stock Co Pharmstandard","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1275000.0,"shares_display":"1,275,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":10200000.0,"total_display":"10,200,000.00","shares_owned_after":5983549.0,"shares_owned_after_display":"5,983,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-12","filed_date":"2014-02-12","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001105533","name":"ARGOS THERAPEUTICS INC","url":"/issuer/0001105533","role":"Ten percent owner","n_filings":13,"first_seen":"2014-02-12","last_seen":"2016-10-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001359931","name":"PROTEON THERAPEUTICS INC","url":"/issuer/0001359931","role":"Ten percent owner","n_filings":1,"first_seen":"2014-10-29","last_seen":"2014-10-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001598762","retrieved_at":"2026-08-21T09:48:02+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}